Source:http://linkedlifedata.com/resource/pubmed/id/15256283
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
1-3
|
pubmed:dateCreated |
2004-7-16
|
pubmed:abstractText |
The role of urotensin II (U-II)--a vasoactive, mitogenic, and inotropic, peptide--in the pathophysiology of heart failure is controversial. The present study explores the relationship between plasma U-II immunoreactivity (U-IIIR) and hemodynamics in patients with coronary artery disease (CAD). Thirty-six patients with CAD-3 undergoing coronary artery bypass grafting (CABG) with cardiopulmonary bypass (CPB) and 36 medical patients (MED group) with CAD-1 to CAD-3 during right heart catheterization were studied. Significant correlations were observed between pulmonary capillary wedge pressure (PCWP) and U-IIIR--determined by enzyme immunoassay (EIA)--before (rho = 0.83) and after (rho = 0.6) cardiopulmonary bypass in the CABG group. With the exception of the CPB period, CABG patients with increased PCWP before CPB had higher U-II(IR) concentrations throughout the procedure. Significant correlations were observed between U-IIIR, proANP, proBNP, and mean right ventricular pressure (RVPM) in MED patients. No correlation was detectable between U-IIIR and PCWP. However, MED patients with CAD-3 (n = 13) had higher levels of U-IIIR, NTproANPIR (RIA), NTproBNPIR (EIA) and higher cardiac filling pressures than patients with CAD-1 (n = 13). These findings support an association between plasma U-IIIR levels and diastolic myocardial dysfunction in ischemic heart failure. The discrepancies regarding left and right cardiac filling pressures and U-IIIR levels in CABG and MED patients require further evaluation.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0167-0115
|
pubmed:author |
pubmed-author:ArmbrusterFranz PaulFP,
pubmed-author:BahlmannLudgerL,
pubmed-author:EleftheriadisSawasS,
pubmed-author:FranzNorbertN,
pubmed-author:HeringlakeMatthiasM,
pubmed-author:KlausStephanS,
pubmed-author:KoxThomasT,
pubmed-author:KraatzErnstE,
pubmed-author:UzunOrhanO,
pubmed-author:WillBarbaraB
|
pubmed:copyrightInfo |
Copyright 2004 Elsevier B.V.
|
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
121
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
129-36
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:15256283-Aged,
pubmed-meshheading:15256283-Case-Control Studies,
pubmed-meshheading:15256283-Coronary Artery Bypass,
pubmed-meshheading:15256283-Coronary Artery Disease,
pubmed-meshheading:15256283-Female,
pubmed-meshheading:15256283-Heart Catheterization,
pubmed-meshheading:15256283-Heart Ventricles,
pubmed-meshheading:15256283-Humans,
pubmed-meshheading:15256283-Immunoenzyme Techniques,
pubmed-meshheading:15256283-Male,
pubmed-meshheading:15256283-Middle Aged,
pubmed-meshheading:15256283-Urotensins,
pubmed-meshheading:15256283-Ventricular Pressure
|
pubmed:year |
2004
|
pubmed:articleTitle |
The relationship between urotensin II plasma immunoreactivity and left ventricular filling pressures in coronary artery disease.
|
pubmed:affiliation |
Klinik für Anaesthesiologie, Universitätsklinikum Schleswig-Holstein, Campus Lübeck, Ratzeburger Allee 160, D-23538 Lübeck, Germany. Heringlake@t-online.de
|
pubmed:publicationType |
Journal Article
|